Results about: patient

IRB Barcelona identifies the gene responsible for metastasis of breast cancer to the bone

A study published today in the Journal of National Cancer Institute (JNCI) by ICREA researcher Roger Gomis may be key to the early detection of patients at risk of developing metastasis to the bone

This new knowledge may accelerate the development of the first preventive treatment of bone metastasis

Inbiomotion, an IRB Barcelona spin off company and financed with venture investors Ysios Capital, has already begun clinical trials

ERC Proof of Concept to Angel R. Nebreda

The European Research Council awards 45 scientists with grants to commercialize their research results

The grant, worth up to €150,000, cover costs of activities to verify the innovation potential of Nebreda’s ERC Advanced Grant-funded project

Nebreda will study new breast cancer therapies